From: The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age (> 40 years vs ≤ 40) | 7.39 (3.52, 15.53) | < 0.001 | 3.80 (1.72, 8.52) | 0.001 |
Sex (male vs. female) | 2.38 (1.37, 4.11) | 0.002 | 2.21 (1.20, 4.07) | 0.011 |
History of exposure (yes vs no) | 0.249 (0.14, 0.44) | < 0.001 | 0.38 (0.20, 0.71) | 0.002 |
Incubation period (days) | 1.01 (0.95, 1.07) | 0.723 | ||
Comorbidities (yes vs no) | 2.86 (1.87, 4.38) | < 0.001 | 1.78 (1.13, 2.81) | 0.013 |
Radiology manifestation (yes vs no) | 5.38 (1.89, 15.35) | 0.002 | 3.56 (1.13, 11.40) | 0.032 |
Symptoms (yes vs no) | 1.02 (0.68, 1.53) | 0.914 | ||
Respiratory rate (> 24 breaths/min) | 1.06 (0.92, 1.21) | 0.480 |